Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 33 |
NetGPI | no | yes: 0, no: 33 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 15 |
GO:0110165 | cellular anatomical entity | 1 | 15 |
Related structures:
AlphaFold database: Q4QI91
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 471 | 475 | PF00656 | 0.422 |
CLV_MEL_PAP_1 | 16 | 22 | PF00089 | 0.404 |
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.282 |
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.411 |
CLV_NRD_NRD_1 | 193 | 195 | PF00675 | 0.629 |
CLV_NRD_NRD_1 | 240 | 242 | PF00675 | 0.600 |
CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.556 |
CLV_NRD_NRD_1 | 350 | 352 | PF00675 | 0.514 |
CLV_NRD_NRD_1 | 423 | 425 | PF00675 | 0.609 |
CLV_NRD_NRD_1 | 453 | 455 | PF00675 | 0.664 |
CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.336 |
CLV_PCSK_FUR_1 | 191 | 195 | PF00082 | 0.469 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.365 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.653 |
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.655 |
CLV_PCSK_KEX2_1 | 240 | 242 | PF00082 | 0.600 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.514 |
CLV_PCSK_KEX2_1 | 452 | 454 | PF00082 | 0.636 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.326 |
CLV_PCSK_PC1ET2_1 | 190 | 192 | PF00082 | 0.479 |
CLV_PCSK_PC1ET2_1 | 452 | 454 | PF00082 | 0.626 |
CLV_PCSK_PC7_1 | 127 | 133 | PF00082 | 0.257 |
CLV_PCSK_PC7_1 | 236 | 242 | PF00082 | 0.605 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 236 | 240 | PF00082 | 0.606 |
CLV_PCSK_SKI1_1 | 273 | 277 | PF00082 | 0.496 |
CLV_PCSK_SKI1_1 | 292 | 296 | PF00082 | 0.567 |
CLV_PCSK_SKI1_1 | 315 | 319 | PF00082 | 0.635 |
CLV_PCSK_SKI1_1 | 385 | 389 | PF00082 | 0.647 |
CLV_PCSK_SKI1_1 | 454 | 458 | PF00082 | 0.469 |
CLV_PCSK_SKI1_1 | 493 | 497 | PF00082 | 0.590 |
DEG_APCC_DBOX_1 | 235 | 243 | PF00400 | 0.431 |
DEG_APCC_DBOX_1 | 453 | 461 | PF00400 | 0.384 |
DEG_APCC_DBOX_1 | 94 | 102 | PF00400 | 0.542 |
DEG_MDM2_SWIB_1 | 172 | 179 | PF02201 | 0.192 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.604 |
DOC_MAPK_DCC_7 | 318 | 328 | PF00069 | 0.350 |
DOC_MAPK_gen_1 | 105 | 114 | PF00069 | 0.557 |
DOC_MAPK_gen_1 | 127 | 135 | PF00069 | 0.575 |
DOC_MAPK_gen_1 | 269 | 280 | PF00069 | 0.337 |
DOC_MAPK_MEF2A_6 | 269 | 278 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 318 | 327 | PF00069 | 0.358 |
DOC_PP1_RVXF_1 | 371 | 377 | PF00149 | 0.326 |
DOC_PP2B_PxIxI_1 | 246 | 252 | PF00149 | 0.320 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.666 |
DOC_USP7_MATH_1 | 360 | 364 | PF00917 | 0.287 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.510 |
DOC_WW_Pin1_4 | 215 | 220 | PF00397 | 0.530 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.609 |
LIG_14-3-3_CanoR_1 | 127 | 131 | PF00244 | 0.531 |
LIG_14-3-3_CanoR_1 | 194 | 200 | PF00244 | 0.429 |
LIG_14-3-3_CanoR_1 | 214 | 219 | PF00244 | 0.584 |
LIG_14-3-3_CanoR_1 | 241 | 247 | PF00244 | 0.412 |
LIG_14-3-3_CanoR_1 | 248 | 252 | PF00244 | 0.406 |
LIG_14-3-3_CanoR_1 | 493 | 501 | PF00244 | 0.366 |
LIG_APCC_ABBAyCdc20_2 | 273 | 279 | PF00400 | 0.360 |
LIG_BRCT_BRCA1_1 | 168 | 172 | PF00533 | 0.249 |
LIG_deltaCOP1_diTrp_1 | 158 | 164 | PF00928 | 0.572 |
LIG_deltaCOP1_diTrp_1 | 492 | 496 | PF00928 | 0.333 |
LIG_FHA_1 | 286 | 292 | PF00498 | 0.393 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.579 |
LIG_FHA_1 | 471 | 477 | PF00498 | 0.411 |
LIG_FHA_1 | 495 | 501 | PF00498 | 0.352 |
LIG_FHA_2 | 207 | 213 | PF00498 | 0.453 |
LIG_FHA_2 | 23 | 29 | PF00498 | 0.727 |
LIG_IRF3_LxIS_1 | 361 | 367 | PF10401 | 0.242 |
LIG_LIR_Gen_1 | 14 | 24 | PF02991 | 0.520 |
LIG_LIR_Gen_1 | 304 | 313 | PF02991 | 0.336 |
LIG_LIR_Gen_1 | 74 | 84 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 14 | 20 | PF02991 | 0.582 |
LIG_LIR_Nem_3 | 158 | 164 | PF02991 | 0.549 |
LIG_LIR_Nem_3 | 173 | 179 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 304 | 308 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 375 | 379 | PF02991 | 0.327 |
LIG_MLH1_MIPbox_1 | 168 | 172 | PF16413 | 0.192 |
LIG_MYND_3 | 296 | 300 | PF01753 | 0.282 |
LIG_NRBOX | 97 | 103 | PF00104 | 0.533 |
LIG_Pex14_2 | 172 | 176 | PF04695 | 0.332 |
LIG_PTB_Apo_2 | 47 | 54 | PF02174 | 0.571 |
LIG_SH2_CRK | 487 | 491 | PF00017 | 0.367 |
LIG_SH2_NCK_1 | 487 | 491 | PF00017 | 0.362 |
LIG_SH2_PTP2 | 17 | 20 | PF00017 | 0.594 |
LIG_SH2_SRC | 487 | 490 | PF00017 | 0.383 |
LIG_SH2_STAP1 | 357 | 361 | PF00017 | 0.332 |
LIG_SH2_STAT3 | 163 | 166 | PF00017 | 0.590 |
LIG_SH2_STAT3 | 431 | 434 | PF00017 | 0.288 |
LIG_SH2_STAT3 | 466 | 469 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.553 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.564 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.515 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.566 |
LIG_SH2_STAT5 | 305 | 308 | PF00017 | 0.340 |
LIG_SH2_STAT5 | 390 | 393 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 431 | 434 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 466 | 469 | PF00017 | 0.403 |
LIG_SH3_3 | 216 | 222 | PF00018 | 0.510 |
LIG_SH3_3 | 366 | 372 | PF00018 | 0.328 |
LIG_SUMO_SIM_anti_2 | 60 | 66 | PF11976 | 0.648 |
LIG_SUMO_SIM_par_1 | 322 | 329 | PF11976 | 0.353 |
LIG_SUMO_SIM_par_1 | 60 | 66 | PF11976 | 0.586 |
LIG_TRAF2_1 | 229 | 232 | PF00917 | 0.389 |
LIG_TRFH_1 | 113 | 117 | PF08558 | 0.468 |
LIG_TYR_ITIM | 485 | 490 | PF00017 | 0.340 |
LIG_UBA3_1 | 286 | 295 | PF00899 | 0.228 |
LIG_UBA3_1 | 417 | 425 | PF00899 | 0.265 |
MOD_CK1_1 | 215 | 221 | PF00069 | 0.488 |
MOD_CK1_1 | 334 | 340 | PF00069 | 0.366 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.597 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.643 |
MOD_CK2_1 | 424 | 430 | PF00069 | 0.373 |
MOD_GlcNHglycan | 168 | 171 | PF01048 | 0.293 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.286 |
MOD_GlcNHglycan | 265 | 268 | PF01048 | 0.574 |
MOD_GlcNHglycan | 470 | 473 | PF01048 | 0.583 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.355 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.451 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.432 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.346 |
MOD_GSK3_1 | 307 | 314 | PF00069 | 0.425 |
MOD_GSK3_1 | 360 | 367 | PF00069 | 0.285 |
MOD_N-GLC_1 | 340 | 345 | PF02516 | 0.525 |
MOD_N-GLC_1 | 40 | 45 | PF02516 | 0.383 |
MOD_N-GLC_1 | 49 | 54 | PF02516 | 0.398 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.498 |
MOD_NEK2_1 | 242 | 247 | PF00069 | 0.420 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.312 |
MOD_NEK2_1 | 326 | 331 | PF00069 | 0.324 |
MOD_NEK2_1 | 364 | 369 | PF00069 | 0.358 |
MOD_NEK2_1 | 403 | 408 | PF00069 | 0.335 |
MOD_NEK2_2 | 180 | 185 | PF00069 | 0.292 |
MOD_PIKK_1 | 55 | 61 | PF00454 | 0.616 |
MOD_PK_1 | 424 | 430 | PF00069 | 0.381 |
MOD_PKA_1 | 240 | 246 | PF00069 | 0.277 |
MOD_PKA_1 | 424 | 430 | PF00069 | 0.421 |
MOD_PKA_2 | 126 | 132 | PF00069 | 0.528 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.594 |
MOD_PKA_2 | 232 | 238 | PF00069 | 0.314 |
MOD_PKA_2 | 240 | 246 | PF00069 | 0.327 |
MOD_PKA_2 | 247 | 253 | PF00069 | 0.311 |
MOD_PKA_2 | 69 | 75 | PF00069 | 0.600 |
MOD_Plk_1 | 334 | 340 | PF00069 | 0.312 |
MOD_Plk_1 | 391 | 397 | PF00069 | 0.425 |
MOD_Plk_1 | 49 | 55 | PF00069 | 0.629 |
MOD_Plk_2-3 | 49 | 55 | PF00069 | 0.582 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.242 |
MOD_Plk_4 | 259 | 265 | PF00069 | 0.287 |
MOD_Plk_4 | 340 | 346 | PF00069 | 0.344 |
MOD_ProDKin_1 | 215 | 221 | PF00069 | 0.529 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.596 |
MOD_SUMO_rev_2 | 266 | 275 | PF00179 | 0.351 |
MOD_SUMO_rev_2 | 427 | 436 | PF00179 | 0.265 |
TRG_DiLeu_BaEn_1 | 147 | 152 | PF01217 | 0.585 |
TRG_DiLeu_BaEn_1 | 322 | 327 | PF01217 | 0.319 |
TRG_ENDOCYTIC_2 | 168 | 171 | PF00928 | 0.304 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.594 |
TRG_ENDOCYTIC_2 | 189 | 192 | PF00928 | 0.350 |
TRG_ENDOCYTIC_2 | 305 | 308 | PF00928 | 0.340 |
TRG_ENDOCYTIC_2 | 487 | 490 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.541 |
TRG_ER_diArg_1 | 130 | 132 | PF00400 | 0.628 |
TRG_ER_diArg_1 | 192 | 194 | PF00400 | 0.456 |
TRG_ER_diArg_1 | 239 | 241 | PF00400 | 0.405 |
TRG_ER_diArg_1 | 350 | 352 | PF00400 | 0.297 |
TRG_ER_diArg_1 | 68 | 71 | PF00400 | 0.636 |
TRG_NES_CRM1_1 | 284 | 300 | PF08389 | 0.355 |
TRG_NES_CRM1_1 | 416 | 430 | PF08389 | 0.267 |
TRG_NLS_MonoExtC_3 | 189 | 194 | PF00514 | 0.266 |
TRG_Pf-PMV_PEXEL_1 | 149 | 154 | PF00026 | 0.375 |
TRG_Pf-PMV_PEXEL_1 | 458 | 462 | PF00026 | 0.575 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAN2 | Leptomonas seymouri | 41% | 77% |
A0A0N1PB02 | Leptomonas seymouri | 50% | 78% |
A0A0S4J6C6 | Bodo saltans | 42% | 79% |
A0A1X0P9A6 | Trypanosomatidae | 50% | 75% |
A0A3Q8IHH1 | Leishmania donovani | 39% | 70% |
A0A3R7K2Y9 | Trypanosoma rangeli | 49% | 74% |
A0A3S5H668 | Leishmania donovani | 95% | 100% |
A0A3S5H669 | Leishmania donovani | 47% | 80% |
A0A3S7X835 | Leishmania donovani | 49% | 91% |
A4H5C9 | Leishmania braziliensis | 75% | 100% |
A4H5D0 | Leishmania braziliensis | 44% | 85% |
A4HAZ7 | Leishmania braziliensis | 45% | 100% |
A4HAZ9 | Leishmania braziliensis | 46% | 82% |
A4HB01 | Leishmania braziliensis | 46% | 87% |
A4HTM0 | Leishmania infantum | 95% | 100% |
A4HTM1 | Leishmania infantum | 45% | 80% |
A4IA57 | Leishmania infantum | 49% | 91% |
C6K3V8 | Leptomonas seymouri | 77% | 84% |
C6K3V9 | Leptomonas seymouri | 42% | 78% |
C9ZMY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 75% |
E8NHE5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 81% |
E8NHF8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 84% |
E9AME6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
E9AME7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 44% | 80% |
E9B571 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 49% | 92% |
Q4Q1U8 | Leishmania major | 38% | 100% |
Q4Q2R4 | Leishmania major | 50% | 100% |
Q4Q310 | Leishmania major | 37% | 100% |
Q4Q312 | Leishmania major | 37% | 100% |
Q4Q340 | Leishmania major | 38% | 100% |
Q4Q342 | Leishmania major | 38% | 100% |
Q4QI90 | Leishmania major | 47% | 100% |